Definitive Healthcare Corp. 8-K Summary
Business Context and Reporting Period
This Current Report (Form 8-K) was filed on September 17, 2021, by Definitive Healthcare Corp. (the "Company"). The filing primarily discloses the entry into a new material definitive credit agreement and the closing of the Company's initial public offering (IPO).
Key Financial Metrics and Capital Structure
- New Debt Facilities: The Company's subsidiary, Definitive Healthcare Holdings, LLC ("DHH"), entered into a credit agreement establishing a $275 million Term Loan A facility and a $75 million Revolving Credit Facility.
- Debt Maturity: Both facilities mature on September 17, 2026.
- Interest Rates: Interest is based on the Base Rate or LIBOR plus a margin ranging from 75 to 225 basis points, dependent on the Total Net Leverage Ratio. Initial margins are 125 basis points (Base Rate) or 225 basis points (LIBOR).
- Amortization: The Term Facility requires quarterly principal amortization starting December 31, 2021, at approximately 2.5% of the principal in years one and two, and 5.0% in years three, four, and five.
- Unused Commitment Fee: The Revolving Credit Facility incurs a fee of 25 to 30 basis points on undrawn commitments.
- Collateral: The facilities are secured by a lien on substantially all of DHH's assets, including fixed assets and intangibles.
- IPO Proceeds: The Company closed its IPO on September 17, 2021, selling 17,888,888 shares of Class A common stock at $27.00 per share, including the full exercise of the underwriters' option to purchase an additional 2,333,333 shares.
Material Changes Versus Prior Period
The filing details a significant refinancing event where the proceeds from the new $350 million total credit facilities were used to repay the remaining indebtedness under a prior credit agreement dated July 16, 2019, with Owl Rock Capital Corporation. Additionally, the Company transitioned from a private entity to a public company through its IPO.
Guidance, Outlook, and Risks
The filing does not provide specific financial guidance or forward-looking revenue projections. However, it notes that the Company is subject to customary affirmative, negative, and financial covenants under the new credit agreement. The Company is designated as an emerging growth company. The primary risk disclosed relates to compliance with the financial covenants and the obligations associated with the new debt structure.
Key Facts for Investor Verification
- Verify the exact net proceeds from the IPO after deducting underwriting discounts and offering expenses.
- Confirm the Company's current Total Net Leverage Ratio to determine the applicable interest rate margins and unused commitment fees.
- Review the full text of the Credit Agreement (Exhibit 10.1) for specific financial covenant thresholds and potential events of default.
- Monitor the Company's cash flow to ensure it can meet the quarterly amortization payments on the Term Facility commencing December 31, 2021.